Two Sigma Securities, LLC Volitionrx LTD Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.72 - $1.19 $7,869 - $13,006	10,930 Added 93.01%	22,682 $17,000
Q4 2023 Feb 14, 2024	SELL	$0.55 - $0.88 $9,019 - $14,431	-16,399 Reduced 58.25%	11,752 $8,000
Q3 2023 Nov 14, 2023	BUY	$0.69 - $1.53 $8,460 - $18,760	12,262 Added 77.17%	28,151 $19,000
Q2 2023 Aug 14, 2023	BUY	$1.39 - $2.02 $8,073 - $11,732	5,808 Added 57.61%	15,889 $22,000
Q1 2023 May 15, 2023	SELL	$1.54 - $2.68 $4,911 - $8,546	-3,189 Reduced 24.03%	10,081 $19,000
Q4 2022 Feb 14, 2023	SELL	$1.39 - $2.6 $29,323 - $54,849	-21,096 Reduced 61.39%	13,270 $32,000
Q3 2022 Nov 14, 2022	BUY	$1.36 - $2.38 $46,737 - $81,791	34,366 New	34,366 $47,000

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $33.8M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.